Title : Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2 years.

Pub. Date : 2011 May 27

PMID : 21478817






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2 years. Everolimus calcineurin binding protein 1 Homo sapiens
2 BACKGROUND: Few studies have examined everolimus therapy with calcineurin inhibitor (CNI) withdrawal in maintenance heart transplant patients. Everolimus calcineurin binding protein 1 Homo sapiens
3 BACKGROUND: Few studies have examined everolimus therapy with calcineurin inhibitor (CNI) withdrawal in maintenance heart transplant patients. Everolimus calcineurin binding protein 1 Homo sapiens
4 METHODS: In a prospective, single-arm, single-center study, CNI-treated heart transplant patients were converted to everolimus and were followed up for 24 months. Everolimus calcineurin binding protein 1 Homo sapiens
5 CONCLUSIONS: CNI-free immunosuppression with everolimus is an effective and safe option in selected heart transplant maintenance patients. Everolimus calcineurin binding protein 1 Homo sapiens